Caris Life Sciences, Inc.CAINYSE
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending higher, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-253.64M
Near historical average
Average (9y)
$-239.93M
Historical baseline
Range
High:$57.57M
Low:$-633.07M
CAGR
+4.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-253.64M | +15.0% |
| 2023 | $-298.42M | +9.0% |
| 2022 | $-327.96M | -669.7% |
| 2020 | $57.57M | +188.4% |
| 2019 | $-65.14M | +89.7% |
| 2018 | $-633.07M | -82.5% |
| 2017 | $-346.98M | -184.4% |
| 2016 | $-121.99M | +49.6% |
| 2015 | $-242.04M | -44.4% |
| 2014 | $-167.62M | - |